At delivery, tissues are safely collected by trained technicians. They are transported overnight to the processing facility. In addition to the serological testing in the pre-screening process, culturing is performed regularly during processing. All products are retested post-processing to ensure the absence of bacterial and fungal pathogens.
During processing, a cryopreservative is introduced to the tissue to protect cell viability.* Once packaged into vials, the products are sent to a third-party testing facility to ensure sterility.
All products undergo a 14-day quarantine period. After 14 days, the product batches are randomly retested to demonstrate a continued absence of bacterial and fungal pathogens and are non-pyrogenic. A licensed medical director reviews all testing results before the products can be released to our partnering practices for clinical use.